2025
213 Focal Atypical Ductal Hyperplasia (ADH) Upgrade Rate with Radiological Correlation: A Single Institution Study
Podany P, Kahila M, Proussaloglou E, Lewin J, Andrejeva L, Krishnamurti U. 213 Focal Atypical Ductal Hyperplasia (ADH) Upgrade Rate with Radiological Correlation: A Single Institution Study. Laboratory Investigation 2025, 105: 102437. DOI: 10.1016/j.labinv.2024.102437.Peer-Reviewed Original Research
2005
Impact of concurrent proliferative high‐risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast‐conserving therapy
Adepoju LJ, Symmans WF, Babiera GV, Singletary SE, Arun B, Sneige N, Pusztai L, Buchholz TA, Sahin A, Hunt KK, Meric‐Bernstam F, Ross MI, Ames FC, Kuerer HM. Impact of concurrent proliferative high‐risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast‐conserving therapy. Cancer 2005, 106: 42-50. PMID: 16333852, DOI: 10.1002/cncr.21571.Peer-Reviewed Original ResearchConceptsAtypical ductal hyperplasiaAtypical lobular hyperplasiaBreast-conserving treatmentBreast carcinoma recurrenceBreast carcinoma developmentCarcinoma recurrenceDuctal carcinomaCarcinoma developmentActuarial local recurrence rateBreast-Conserving TherapyLocal recurrence rateCases of DCISCBC developmentHigh-risk lesionsLobular hyperplasiaConcurrent diagnosisDuctal hyperplasiaInitial pathologyLobular carcinomaRecurrence rateChemoprevention strategiesCumulative rateDCISPatientsProliferative lesions
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply